speb/financial-data huggingface dataset:
IBRX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 39007000.00
IBRX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 1198000.00
IBRX balance_sheet (annual, 2024-12-31) — Goodwill: 910000.00
IBRX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 15933000.00
IBRX balance_sheet (annual, 2024-12-31) — Gross PPE: 270046000.00
IBRX income_statement (annual, 2024-12-31) — Gross Profit: 14745000.00
IBRX income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
IBRX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 15000.00
IBRX cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
IBRX income_statement (annual, 2024-12-31) — Interest Expense: 131740000.00
IBRX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 131740000.00
IBRX income_statement (annual, 2024-12-31) — Interest Income: 2400000.00
IBRX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2400000.00
IBRX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 92318000.00
IBRX balance_sheet (annual, 2024-12-31) — Inventory: 8272000.00
IBRX balance_sheet (annual, 2024-12-31) — Invested Capital: -27221000.00
IBRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -12246000.00
IBRX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 0.00
IBRX balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
IBRX balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
IBRX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 111357000.00
IBRX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
IBRX cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Leases: 73126000.00
IBRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 34823000.00
IBRX balance_sheet (annual, 2024-12-31) — Long Term Debt: 461877000.00
IBRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 496700000.00
IBRX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
IBRX cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
IBRX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -64000.00
IBRX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3562000.00
IBRX balance_sheet (annual, 2024-12-31) — Minority Interest: 969000.00
IBRX income_statement (annual, 2024-12-31) — Minority Interests: 81000.00
IBRX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
IBRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 111357000.00
IBRX balance_sheet (annual, 2024-12-31) — Net Debt: 318449000.00
IBRX income_statement (annual, 2024-12-31) — Net Income: -413564000.00
IBRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -413564000.00
IBRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -413645000.00
IBRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -413564000.00
IBRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -413564000.00
IBRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -413645000.00
IBRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -413645000.00
IBRX cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
IBRX income_statement (annual, 2024-12-31) — Net Interest Income: -151927000.00
IBRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -4358000.00
IBRX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -64000.00
IBRX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -64000.00
IBRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -151927000.00
IBRX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 96956000.00
IBRX cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
IBRX cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -1000000.00
IBRX cash_flow (quarterly, 2024-12-31) — Net Other Investing Changes: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Net PPE: 170457000.00
IBRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -6888000.00
IBRX cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -505031000.00
IBRX balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 7130000.00
IBRX income_statement (annual, 2024-12-31) — Normalized EBITDA: -303358000.00
IBRX income_statement (annual, 2024-12-31) — Normalized Income: -452571000.00
IBRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -391236000.00
IBRX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -33432000.00
IBRX income_statement (annual, 2024-12-31) — Operating Income: -344182000.00
IBRX income_statement (annual, 2024-12-31) — Operating Revenue: 14150000.00
IBRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 852904340.00
IBRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 1303000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1050000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 1198000.00
IBRX income_statement (annual, 2024-12-31) — Other Income Expense: 82464000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 15023000.00
IBRX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 24134000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 4827000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 284723000.00
IBRX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 43457000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Properties: 106941000.00
IBRX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 6381000.00
IBRX balance_sheet (annual, 2024-12-31) — Payables: 6898000.00
IBRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 31403000.00
IBRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 15025000.00
IBRX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 22549000.00
IBRX income_statement (annual, 2024-12-31) — Pretax Income: -413645000.00
IBRX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 73381000.00
IBRX balance_sheet (annual, 2024-12-31) — Properties: 0.00
IBRX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
IBRX cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
IBRX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -140965000.00
IBRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -6888000.00
IBRX balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
IBRX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Receivables: 2653000.00
IBRX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 0.00
IBRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 17554000.00
IBRX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -64000.00
IBRX income_statement (annual, 2024-12-31) — Research And Development: 190144000.00
IBRX balance_sheet (annual, 2024-12-31) — Retained Earnings: -3375248000.00
IBRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 136607000.00
IBRX income_statement (annual, 2024-12-31) — Selling General And Administration: 168783000.00
IBRX balance_sheet (annual, 2024-12-31) — Share Issued: 853068140.00
IBRX cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
IBRX income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
IBRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 34432000.00
IBRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: -489098000.00
IBRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -505031000.00
IBRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IBRX income_statement (annual, 2024-12-31) — Tax Provision: 0.00
IBRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
IBRX balance_sheet (annual, 2024-12-31) — Total Assets: 382933000.00
IBRX balance_sheet (annual, 2024-12-31) — Total Capitalization: -27221000.00
IBRX balance_sheet (annual, 2024-12-31) — Total Debt: 504166000.00
IBRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -488129000.00
IBRX income_statement (annual, 2024-12-31) — Total Expenses: 358927000.00
IBRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 871062000.00
IBRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 198347000.00
IBRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 816118000.00
IBRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -344182000.00
IBRX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 22587000.00
IBRX income_statement (annual, 2024-12-31) — Total Unusual Items: 39007000.00
IBRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 39007000.00
IBRX balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 163800.00
IBRX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 632000.00
IBRX cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 112000.00
IBRX balance_sheet (annual, 2024-12-31) — Work In Process: 7505000.00
IBRX balance_sheet (quarterly, 2024-12-31) — Work In Process: 7505000.00
IBRX balance_sheet (annual, 2024-12-31) — Working Capital: 129642000.00
IBRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 80888000.00
IBRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 16517000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 13501000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 17029000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -102935000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2893422000.00
IBRX cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -52000.00
IBRX cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
IBRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 853162000.00
IBRX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.15
IBRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 143912000.00
IBRX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1121000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 40557000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 85000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 60660000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 61591000.00
IBRX cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -982000.00
IBRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 4129000.00
IBRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -85905000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 6439000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -12933000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -172000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -84000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1732000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 51000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Payable: 6439000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -6494000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1065000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -14669000.00
IBRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -22035000.00
IBRX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -14669000.00
IBRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: -82758000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 85000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -591431000.00
IBRX cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
IBRX balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 86433000.00
IBRX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 58000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 15711000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 109163000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 7460000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 7460000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 49205000.00
IBRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3829000.00
IBRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3829000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 29565000.00
IBRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 853162000.00
IBRX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.15
IBRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -129646000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 424000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 355000.00
IBRX income_statement (quarterly, 2025-03-31) — EBIT: -101035000.00
IBRX income_statement (quarterly, 2025-03-31) — EBITDA: -97206000.00
IBRX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -10000.00
IBRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 61144000.00
IBRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -982000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Finished Goods: 937000.00
IBRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -87026000.00
IBRX cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -5130000.00
IBRX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 5497000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 19956000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Goodwill: 910000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 15443000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 269985000.00
IBRX income_statement (quarterly, 2025-03-31) — Gross Profit: 16459000.00
IBRX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
IBRX income_statement (quarterly, 2025-03-31) — Interest Expense: 28865000.00
IBRX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 28865000.00
IBRX income_statement (quarterly, 2025-03-31) — Interest Income: 520000.00
IBRX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 520000.00
IBRX cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 15593000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Inventory: 8444000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: -105714000.00
IBRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 4129000.00
IBRX cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
IBRX balance_sheet (quarterly, 2025-03-31) — Leases: 73279000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 33097000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 485717000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 518814000.00
IBRX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
IBRX balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3578000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Minority Interest: 949000.00
IBRX income_statement (quarterly, 2025-03-31) — Minority Interests: 20000.00
IBRX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
IBRX balance_sheet (quarterly, 2025-03-31) — Net Debt: 425057000.00
IBRX income_statement (quarterly, 2025-03-31) — Net Income: -129646000.00
IBRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -129646000.00
IBRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -129666000.00
IBRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -129646000.00
IBRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -129646000.00
IBRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -129666000.00
IBRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -129666000.00
IBRX cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
IBRX income_statement (quarterly, 2025-03-31) — Net Interest Income: -28345000.00
IBRX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 5250000.00
IBRX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
IBRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -28345000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Net PPE: 167050000.00
IBRX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1121000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -606874000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 7192000.00
IBRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -102703000.00
IBRX income_statement (quarterly, 2025-03-31) — Normalized Income: -135133097.78
IBRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -85905000.00
IBRX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -5130000.00
IBRX income_statement (quarterly, 2025-03-31) — Operating Income: -64429000.00
IBRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 16509000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 853556193.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2353000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 2651000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 19956000.00
IBRX income_statement (quarterly, 2025-03-31) — Other Income Expense: -37126000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 14533000.00
IBRX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 15030000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4911000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 296657000.00
IBRX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -42623000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Properties: 106695000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 931000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Payables: 13856000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 29567000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 9527000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 19322000.00
IBRX income_statement (quarterly, 2025-03-31) — Pretax Income: -129900000.00
IBRX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: -982000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: 0.00
IBRX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -100000.00
IBRX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1121000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 0.00
IBRX balance_sheet (quarterly, 2025-03-31) — Receivables: 17453000.00
IBRX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 58000.00
IBRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3829000.00
IBRX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: 0.00
IBRX income_statement (quarterly, 2025-03-31) — Research And Development: 48234000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3504894000.00
IBRX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 5350000.00
IBRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 32654000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 853719993.00
IBRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 9537000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -591431000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -606874000.00
IBRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 9902.22
IBRX income_statement (quarterly, 2025-03-31) — Tax Provision: -234000.00
IBRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 303759000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -105714000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 526274000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -590482000.00
IBRX income_statement (quarterly, 2025-03-31) — Total Expenses: 80946000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 894241000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 194596000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 845036000.00
IBRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -64429000.00
IBRX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 5497000.00
IBRX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 5497000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 163800.00
IBRX cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 42582000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Work In Process: 7507000.00
IBRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 59958000.00
IBRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 97574000.00
IBRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 26425000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 7419000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 22126000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -105872000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 3014041000.00
IBRX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -11000.00
IBRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 888216000.00
IBRX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.10
IBRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 61144000.00
IBRX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1081000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 43232000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 91000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 137658000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 153658000.00
IBRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 172810000.00
IBRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -16142000.00
IBRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -79746000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -6216000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 8723000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1804000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1227000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1844000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -7000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Payable: -6216000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2507000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -4144000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -5097000.00
IBRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -5554000.00
IBRX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -5097000.00
IBRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 76922000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 91000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -570749000.00
IBRX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 173136000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 86433000.00
IBRX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 136000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 18687000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 208132000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 7392000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 7392000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 50644000.00
IBRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3880000.00
IBRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3880000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 85568000.00
IBRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 888216000.00
IBRX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.10
IBRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -92555000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 204000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 128000.00
IBRX income_statement (quarterly, 2025-06-30) — EBIT: -63421000.00
IBRX income_statement (quarterly, 2025-06-30) — EBITDA: -59541000.00
IBRX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 76000.00
IBRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 138142000.00
IBRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 172810000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 801000.00
IBRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -80827000.00
IBRX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -5820000.00
IBRX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 6155000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 12568000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Goodwill: 910000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14977000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 273599000.00
IBRX income_statement (quarterly, 2025-06-30) — Gross Profit: 26289000.00
IBRX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
IBRX income_statement (quarterly, 2025-06-30) — Interest Expense: 28884000.00
IBRX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 28884000.00
IBRX income_statement (quarterly, 2025-06-30) — Interest Income: 818000.00
IBRX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 818000.00
IBRX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 18865000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Inventory: 6640000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: -78665000.00
IBRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -16142000.00
IBRX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 173136000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Leases: 73161000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 35840000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 492084000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 527924000.00
IBRX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -4000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3560000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Minority Interest: 930000.00
IBRX income_statement (quarterly, 2025-06-30) — Minority Interests: 19000.00
IBRX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 173136000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Net Debt: 354426000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Income: -92555000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -92555000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -92574000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -92555000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -92555000.00
IBRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -92574000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -92574000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Interest Income: -28066000.00
IBRX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -15061000.00
IBRX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -4000.00
IBRX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -4000.00
IBRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -28066000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Net PPE: 167727000.00
IBRX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1081000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -585726000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 7254000.00
IBRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -65696000.00
IBRX income_statement (quarterly, 2025-06-30) — Normalized Income: -97417450.00
IBRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -79746000.00
IBRX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -5820000.00
IBRX income_statement (quarterly, 2025-06-30) — Operating Income: -71285000.00
IBRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 26421000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 915625053.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1642000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1944000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 12568000.00
IBRX income_statement (quarterly, 2025-06-30) — Other Income Expense: 7046000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 14067000.00
IBRX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 53267000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 3986000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 307759000.00
IBRX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 891000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Properties: 110445000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 16000000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Payables: 7547000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 26234000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 15074000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 23862000.00
IBRX income_statement (quarterly, 2025-06-30) — Pretax Income: -92305000.00
IBRX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: -322000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
IBRX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -15061000.00
IBRX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1081000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 0.00
IBRX balance_sheet (quarterly, 2025-06-30) — Receivables: 22330000.00
IBRX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 136000.00
IBRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3880000.00
IBRX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4000.00
IBRX income_statement (quarterly, 2025-06-30) — Research And Development: 55236000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -3597449000.00
IBRX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
IBRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 42338000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 915788853.00
IBRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 9648000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -570749000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -585726000.00
IBRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 1292550.00
IBRX income_statement (quarterly, 2025-06-30) — Tax Provision: 269000.00
IBRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
IBRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 402076000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -78665000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 535316000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -569819000.00
IBRX income_statement (quarterly, 2025-06-30) — Total Expenses: 97710000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 971895000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 193944000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 921251000.00
IBRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -71285000.00
IBRX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 6155000.00
IBRX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 6155000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 163800.00
IBRX balance_sheet (quarterly, 2025-06-30) — Work In Process: 5839000.00
IBRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 157488000.00
IBRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 87514000.00
IBRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 32061000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5773000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 32016000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -109251000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 3135288000.00
IBRX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -978000.00
IBRX income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
IBRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 946601000.00
IBRX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.07
IBRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 138142000.00
IBRX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -775000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 41446000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 98000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 60241000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 257813000.00
IBRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 173519000.00
IBRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -181361000.00
IBRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -68907000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1392000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 5469000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -63000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -324000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1793000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 501000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Payable: -1392000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 4077000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -4840000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -9890000.00
IBRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -12332000.00
IBRX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -9890000.00
IBRX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -76749000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 98000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -524319000.00
IBRX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 173682000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 86266000.00
IBRX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 177000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 23988000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 329497000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 7316000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 7316000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 57134000.00
IBRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3951000.00
IBRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3951000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 133482000.00
IBRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 946601000.00
IBRX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.07
IBRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -67253000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 18000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 443000.00
IBRX income_statement (quarterly, 2025-09-30) — EBIT: -39725000.00
IBRX income_statement (quarterly, 2025-09-30) — EBITDA: -35774000.00
IBRX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -56000.00
IBRX cash_flow (quarterly, 2025-09-30) — End Cash Position: 61337000.00
IBRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 173519000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 2269000.00
IBRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -69682000.00
IBRX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: -15194000.00
IBRX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 16489000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 4997000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Goodwill: 910000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14475000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 272043000.00
IBRX income_statement (quarterly, 2025-09-30) — Gross Profit: 31884000.00
IBRX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
IBRX income_statement (quarterly, 2025-09-30) — Interest Expense: 27584000.00
IBRX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 27584000.00
IBRX income_statement (quarterly, 2025-09-30) — Interest Income: 772000.00
IBRX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 772000.00
IBRX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 18274000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Inventory: 6703000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: -23515000.00
IBRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -181361000.00
IBRX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 173682000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Leases: 73151000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 34130000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 500804000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 534934000.00
IBRX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -12000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3560000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Minority Interest: 909000.00
IBRX income_statement (quarterly, 2025-09-30) — Minority Interests: 21000.00
IBRX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 173682000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Net Debt: 440563000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Income: -67253000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -67253000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -67274000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -67253000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -67253000.00
IBRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -67274000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -67274000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Interest Income: -26812000.00
IBRX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -180586000.00
IBRX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -12000.00
IBRX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -12000.00
IBRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -26812000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Net PPE: 162792000.00
IBRX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -741000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -538794000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 7317000.00
IBRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -52263000.00
IBRX income_statement (quarterly, 2025-09-30) — Normalized Income: -83733425.89
IBRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -68907000.00
IBRX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -15194000.00
IBRX income_statement (quarterly, 2025-09-30) — Operating Income: -55630000.00
IBRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 31780000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 984965179.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2513000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2117000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 4997000.00
IBRX income_statement (quarterly, 2025-09-30) — Other Income Expense: 15133000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 13565000.00
IBRX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 14042000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 4906000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 316847000.00
IBRX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1356000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Properties: 109066000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1683000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 197572000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Payables: 6216000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 30204000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 17497000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 28751000.00
IBRX income_statement (quarterly, 2025-09-30) — Pretax Income: -67309000.00
IBRX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: -151000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
IBRX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -180586000.00
IBRX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -741000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Receivables: 33717000.00
IBRX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 177000.00
IBRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3951000.00
IBRX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -12000.00
IBRX income_statement (quarterly, 2025-09-30) — Research And Development: 51232000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -3664702000.00
IBRX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
IBRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 36282000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 985128979.00
IBRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 8878000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -524319000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -538794000.00
IBRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 8574.11
IBRX income_statement (quarterly, 2025-09-30) — Tax Provision: -35000.00
IBRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 518987000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -23515000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 542250000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -523410000.00
IBRX income_statement (quarterly, 2025-09-30) — Total Expenses: 87691000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1042397000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 189490000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 985263000.00
IBRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -55630000.00
IBRX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 16489000.00
IBRX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 16489000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 163800.00
IBRX balance_sheet (quarterly, 2025-09-30) — Work In Process: 4434000.00
IBRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 272363000.00
IBRX income_statement (annual, 2025-12-31) — +Operating Expense: 368562000.00
IBRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 102586000.00